IKZF3
protein-codingIKAROS family zinc finger 3, the group of Zinc fingers C2H2-type
Gene summary
This gene encodes a member of the Ikaros family of zinc-finger proteins. Three members of this protein family (Ikaros, Aiolos and Helios) are hematopoietic-specific transcription factors involved in the regulation of lymphocyte development. This gene product is a transcription factor that is important in the regulation of B lymphocyte proliferation and differentiation. Both Ikaros and Aiolos can participate in chromatin remodeling. Regulation of gene expression in B lymphocytes by Aiolos is complex as it appears to require the sequential formation of Ikaros homodimers, Ikaros/Aiolos heterodimers, and Aiolos homodimers. Several alternative transcripts encoding different isoforms have been described, as well as some non-protein coding variants. [provided by RefSeq, Apr 2012]
- ZNFN1A3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~106.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0030333
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0030333
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0030333
Submitter: ClinGen
The IKZF3 gene encodes the transcription factor Aiolos. Aiolos is a member of the Ikaros family; as a transcription factor, it can bind DNA in essential regions to control hematopoiesis and cell functions of immune cells. Immunodeficiency 84 or immunodeficiency due to IKZF3 deficiency (MONDO:0030333), is characterized by profound defects in B cell differentiation, and severe hypogammaglobulinemia in patients. A total of two missense variants have been reported in 7 patients in 2 publications only (PMID: 34155405, 34694366). The two variants: p.G159R and p.N160S were found in autosomal dominant traits. Experimental evidence includes loss of the ability to form pericentromeric heterochromatin foci in the dimer IKZF1-IKZF3 affecting the transcriptional activity of genes under IKZF3 regulation. Additionally, the Aiolos knock in mice evaluating the homologous variants for p.G159R, and p.N160S showed that mice have profound defects in B cell development and low immunoglobulin levels (IgG, IgM and IgA), which is consistent with the phenotype seen in patients. In summary, there is moderate evidence to support this gene-disease relationship with only two variants identified in two publications. Note from SCID-CID GCEP added 11/06/2026: IKZF3 (encoding the transcription factor AIOLOS) is a member of the IKAROS zinc finger family located on chromosome 17q21. Germline IKZF3 variants are associated primarily with defects in B cell development and function, though combined immunodeficiency and immune dysregulation phenotypes are also critical features, and the latter includes malignancies, autoimmunity and atopy (PMID: 34265590; PMID: 35444653).
Inheritance Pattern: AD
Disease ID:MONDO:0030333
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Oncologic
Intervention: Allergy/Immunology/Infectious; Oncologic
Rationale: Individuals may be susceptible to infections, and early and aggressive treatment of infections may be beneficial; Lymphoma has been described, and awareness may allow early detection and management; BMT has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to IKZF3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012481.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 1 | 5 | |||
| missense | 1 | 61 | 2 | 64 | ||
| nonsense | 1 | 1 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 1 | 2 | 63 | 6 | 1 | 73 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036613.2 | 8 | MANE Select | |
| Ensembl | ENSP00000344544.3 | 8 | MANE Select | |
| RefSeq | NP_001244337.1 | 7 | Standard | |
| RefSeq | NP_001244338.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- il-2 receptor beta chain in t cell activation
- IL2-mediated signaling events
Biological Process
- regulation of transcription by RNA polymerase II
- mesoderm development
- response to bacterium
- regulation of B cell proliferation
- B cell activation
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000346872
- Coding exons
- 8
- Length
- 99244
- Individuals with no LoFs
- 125723
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 5
- Defined
- 125728
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.14 | 203 | 309 | 0.657 | 0.0000185 | 3420 |
| Missense (PolyPhen) | 47 | 137.84 | 0.34097 | 1481 | ||
| Synonymous | 0.374 | 105 | 110 | 0.955 | 0.00000695 | 892 |
| Loss of Function | 3.89 | 2 | 21.4 | 0.0934 | 0.00000106 | 286 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000035 | 0.000035 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor that plays an important role in the regulation of lymphocyte differentiation. Plays an essential role in regulation of B-cell differentiation, proliferation and maturation to an effector state. Involved in regulating BCL2 expression and controlling apoptosis in T-cells in an IL2- dependent manner. {ECO:0000269|PubMed:10369681}.;
Recessive Scores
- pRec
- 0.211
Intolerance Scores
- LoFtool
- 0.116
- RVIS EVS
- -0.34
- RVIS percentile EVS
- 30.56
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.853
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |